NIH-funded research R01 grant

Understanding how Toxoplasma survives in human cells

Official title: Restriction of Toxoplasma growth in human cells

Funded at University of California at Davis · NIH-10984987 · Data updated 2026-11-12

This study is looking at how the Toxoplasma gondii parasite, which can cause illness, survives in our bodies and how our immune system tries to fight it off, with the hope of finding better treatments for people who are at risk of getting really sick from it.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California at Davis
NIH-funded
Lab location1 site (Davis, United States)
Project startNovember 13, 2023
Project endOctober 31, 2028
Funding year2025
Award (this year)$596,966
NIH project number5R01AI173803-02
Project IDNIH-10984987 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who are immunocompromised or those who may be at risk for severe toxoplasmosis, such as pregnant women or individuals with HIV/AIDS.

Less likely to help

Patients who are not at risk for toxoplasmosis or those with a fully functioning immune system may not benefit from this research.

What this research studies

This research investigates how the Toxoplasma gondii parasite survives and grows within human cells, particularly focusing on the immune responses triggered by cytokines like TNFα. The study aims to uncover the mechanisms by which human immune cells can detect and eliminate Toxoplasma, as well as how the parasite evades these defenses. By using primary human cells in laboratory settings, researchers will explore the interactions between the parasite and the immune system, which could lead to new treatments for those at risk of severe toxoplasmosis.

Why it matters

Potential benefit: If successful, this research could lead to targeted therapies that reduce the health impacts of toxoplasmosis in vulnerable populations.

How similar studies have gone: Previous research has shown promising results in understanding immune responses to Toxoplasma in animal models, but this specific approach in human cells is relatively novel.

Where this research is happening

  • University of California at Davis
    Davis, United States
    Active

Researchers

  • Principal investigator: Saeij, Jeroen — University of California at Davis
  • Study coordinator: Saeij, Jeroen

Related research

Other NIH-funded projects on the same topics.

  • UC Davis IGA Innovation Center

    A research center at UC Davis will study gene-edited livestock to improve animal health, safety, and policy through sharing genetic data and findings about genome edits in cattle, pigs, sheep, and goats.

    NIH research University of California at Davis · Davis, United States · NIH-11641870

  • Administrative Core of an equitable breast cancer screening program

    A national program headed from UC Davis is coordinating several research efforts to improve how breast cancer screening is done in community settings.

    NIH research University of California at Davis · Davis, United States · NIH-11622111

  • The role of novelty and surprise in learning for people with Alzheimer’s disease

    A study explores how surprising events affect memory and learning in people related to Alzheimer’s disease, using everyday tasks to see how the brain remembers new information.

    NIH research University of California at Davis · Davis, United States · NIH-11617755

  • Understanding how distraction affects students and how to measure it better

    This grant studies why distracted students, including those with ADHD, struggle in real-life learning and tests a clearer way to measure distraction in everyday settings.

    NIH research University of California at Davis · Davis, United States · NIH-11617018

  • California Partnership for Personalized Nutrition

    A California clinical center is testing personalized dietary approaches to improve blood sugar and health for adults with diabetes by using big data and AI to tailor meals.

    NIH research University of California at Davis · Davis, United States · NIH-11605720

  • Advancing gastric cancer care for Latinos through patient-derived tumor models

    Aimed at Latinos with gastric cancer, this project uses patient-derived tumor models to study how cancer biology and treatments work in real tumors.

    NIH research University of California at Davis · Davis, United States · NIH-11603175

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.